These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 23803105

  • 1. Urinary bladder cancer risk factors: a Lebanese case- control study.
    Kobeissi LH, Yassine IA, Jabbour ME, Moussa MA, Dhaini HR.
    Asian Pac J Cancer Prev; 2013; 14(5):3205-11. PubMed ID: 23803105
    [Abstract] [Full Text] [Related]

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 3. N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population.
    Yassine IA, Kobeissi L, Jabbour ME, Dhaini HR.
    J Oncol; 2012 Apr; 2012():512976. PubMed ID: 22956951
    [Abstract] [Full Text] [Related]

  • 4. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ.
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [Abstract] [Full Text] [Related]

  • 5. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I, Roots I, Brockmöller J.
    Cancer Res; 2001 Jul 01; 61(13):5051-6. PubMed ID: 11431340
    [Abstract] [Full Text] [Related]

  • 6. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC, Johnson LR, Bell DA, Taylor JA.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 01; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
    Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM.
    Carcinogenesis; 2006 Jan 01; 27(1):103-11. PubMed ID: 15987714
    [Abstract] [Full Text] [Related]

  • 8. Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk.
    Kellen E, Zeegers M, Paulussen A, Vlietinck R, Vlem EV, Veulemans H, Buntinx F.
    Cancer Lett; 2007 Jan 08; 245(1-2):51-60. PubMed ID: 16504378
    [Abstract] [Full Text] [Related]

  • 9. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
    Hosen MB, Islam J, Salam MA, Islam MF, Hawlader MZ, Kabir Y.
    Asia Pac J Clin Oncol; 2015 Mar 08; 11(1):78-84. PubMed ID: 25376209
    [Abstract] [Full Text] [Related]

  • 10. Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking.
    Lu CM, Chung MC, Huang CH, Ko YC.
    Urol Int; 2005 Mar 08; 75(4):360-4. PubMed ID: 16327307
    [Abstract] [Full Text] [Related]

  • 11. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T.
    Urol Oncol; 2013 Oct 08; 31(7):1184-92. PubMed ID: 24075358
    [Abstract] [Full Text] [Related]

  • 12. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S.
    Int J Cancer; 2004 Jul 01; 110(4):598-604. PubMed ID: 15122594
    [Abstract] [Full Text] [Related]

  • 13. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk.
    Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, Sellers TA, Folsom AR, Hein DW.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 01; 8(3):233-9. PubMed ID: 10090301
    [Abstract] [Full Text] [Related]

  • 14. Life style and occupational risk factors for bladder cancer in Germany. A case-control study.
    Kunze E, Chang-Claude J, Frentzel-Beyme R.
    Cancer; 1992 Apr 01; 69(7):1776-90. PubMed ID: 1551063
    [Abstract] [Full Text] [Related]

  • 15. CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population.
    Basma HA, Kobeissi LH, Jabbour ME, Moussa MA, Dhaini HR.
    Int J Mol Epidemiol Genet; 2013 Apr 01; 4(4):207-17. PubMed ID: 24319536
    [Abstract] [Full Text] [Related]

  • 16. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
    Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, Golka K, Okkels H, Risch A, Rothman N, Sim E, Taioli E.
    Cancer Epidemiol Biomarkers Prev; 2001 Dec 01; 10(12):1249-52. PubMed ID: 11751441
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M, Michaud D, De Vivo I.
    BMC Cancer; 2006 Oct 06; 6():239. PubMed ID: 17026750
    [Abstract] [Full Text] [Related]

  • 18. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
    Schroeder JC, Conway K, Li Y, Mistry K, Bell DA, Taylor JA.
    Cancer Res; 2003 Nov 01; 63(21):7530-8. PubMed ID: 14612556
    [Abstract] [Full Text] [Related]

  • 19. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
    Wang CY, Jones RF, Debiec-Rychter M, Soos G, Haas GP.
    Anticancer Res; 2002 Nov 01; 22(6B):3529-35. PubMed ID: 12552951
    [Abstract] [Full Text] [Related]

  • 20. Bladder cancer and coffee consumption in smokers and non-smokers in Spain.
    Escolar Pujolar A, González CA, López-Abente G, Errezola M, Izarzugaza I, Nebot M, Riboli E.
    Int J Epidemiol; 1993 Feb 01; 22(1):38-44. PubMed ID: 8449645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.